Clinical guide
Drug and Alcohol Screening Tests: 15 Tools, Uses, and Diagnostic Limits
Compare 15 drug and alcohol screening and assessment tools by population, substance, format, purpose, and diagnostic limits.
By Paul James Roeser·Reviewed by Noelle Mathew, LCSW, LCADC, CASAC-M·Last reviewed September 10, 2026·5 min read
Published ·Updated
Drug and alcohol screening tests estimate the likelihood of risky or unhealthy substance use and identify who may need further evaluation. They are not interchangeable with a diagnosis, a level-of-care assessment, a breath alcohol measurement, or a laboratory drug test.
Screening supports early detection by turning a concern into a structured conversation. A positive result can lead to feedback, brief intervention, or diagnostic assessment; a negative result does not override overdose, severe withdrawal, dangerous impairment, or another urgent clinical concern.
Tool purpose, population, substance coverage, format, and follow-up determine whether a screen is useful in a particular setting. Individual questions and scoring should be administered according to the responsible authority's current instructions.
Tool performance depends on the population, setting, language, threshold, administration, and outcome being measured. A questionnaire score cannot be generalized to a specimen result, and neither category is universally accurate.
What does a drug and alcohol screening test measure?
A screening test measures reported use, use-related behavior, consequences, or symptoms that raise or lower concern about unhealthy substance use. The instrument may ask about recent frequency, loss of control, hazardous situations, cravings, or functional harm.
Screening becomes appropriate when behavioral, physical, psychological, or social signs of addiction raise concern or when routine care calls for a validated risk check. The screen structures the next conversation; the observed signs still require clinical context.
The result is an estimate that guides the next conversation. A qualified clinician considers the person's history, presentation, medical and psychiatric symptoms, and safety before making a diagnosis.
How are the 15 screening and assessment tools different?
The tools differ by the question they answer, the people they were designed for, and the action that follows a result. The table is a selection map, not a substitute for each tool's scoring or administration instructions.
| Tool or framework | Primary question | Best-fit scope | Result use |
|---|---|---|---|
| NIDA Drug Use Screening Tool | Is drug use concern present? | Legacy adult workflow | Historical context; use current NIDA-listed tools |
| SBIRT | What response fits the risk? | Public-health workflow | Screen, intervene briefly, or refer |
| CRAFFT | Is substance-related risk present in a young person? | Adolescents and young adults | Confidential conversation or assessment |
| Breathalyzer | Is alcohol present in exhaled breath now? | Current alcohol exposure | Immediate measurement; not addiction diagnosis |
| AUDIT | Does alcohol use show hazardous or harmful patterns? | Adults and alcohol-focused care | Feedback, intervention, or assessment |
| DAST-10 | Does drug use create related problems? | Adults and drug-focused care | Further evaluation or intervention |
| MAST | Does drinking history suggest alcohol dependence? | Alcohol-focused assessment | Further clinical evaluation |
| CAGE | Has alcohol use prompted concern or a wish to cut down? | Brief adult alcohol conversation | Follow-up questions or assessment |
| ASSIST | What substance-specific risk is present? | Multiple substances | Risk-based intervention or referral |
| Oral-fluid drug test | Is a selected drug or metabolite detected in a specimen? | Recent exposure monitoring | Specimen result; not a use-disorder diagnosis |
| SASSI | Does the response pattern suggest substance-use risk? | Specialized assessment settings | Follow-up evaluation |
| POSIT | Are multiple problem areas present in a teenager? | Adolescent behavioral health | Broader assessment |
| SDS | How strong are dependence-related experiences? | Substance-specific research or clinical use | Severity information within a larger evaluation |
| ASI | Which life domains need assessment? | Comprehensive addiction assessment | Multidomain treatment planning |
| SUDDS | Do symptoms meet diagnostic criteria? | Structured diagnostic interview | Diagnosis by a trained professional |
Tool availability, validation, and recommended use vary by setting. Confirm current instructions with the responsible health authority or trained clinician.
How should someone choose a screening tool?
Choose a tool by age, substance, setting, purpose, time, privacy, and available follow-up care. An alcohol-focused questionnaire fits a drinking concern; a multi-substance tool fits several substances; an adolescent instrument should not be used as an adult instrument without appropriate validation.
A clinician or trained health professional also considers language, literacy, cultural context, current intoxication, pregnancy, medical risk, and whether the result can be discussed confidentially.
How does SBIRT use screening?
SBIRT uses screening as the first part of a three-part workflow: screening identifies risk, brief intervention addresses the result, and referral connects people to more intensive evaluation or treatment when needed.
Interactive guide
What is the difference between screening, diagnosis, and testing?
Screening estimates behavioral risk, diagnosis determines whether clinical criteria are met, and biological testing detects a substance or metabolite in a specimen. A breath or oral-fluid result may answer whether recent exposure is detected; it does not establish impaired control, functional impairment, or a substance use disorder.
A structured diagnostic interview such as SUDDS belongs to the assessment process, while a screening questionnaire is an earlier triage step. The distinction prevents a score or specimen result from being treated as a diagnosis.
When depression, anxiety, trauma, mood elevation, or suicide risk is the presenting concern, mental-health screening tests use condition-specific symptom instruments; like substance-use screens, their results require clinical evaluation rather than self-diagnosis.
What happens after a positive screening result?
A positive result should lead to a proportionate response, not an automatic treatment placement. Lower-risk findings may lead to feedback and a brief intervention; persistent harm, loss of control, withdrawal, or safety concerns support fuller clinical assessment.
Valley Spring's free drug and alcohol pre-assessment is an intake conversation that identifies immediate concerns and whether a complete clinical evaluation is appropriate.
When a screen indicates persistent harm, loss of control, withdrawal, or substantial risk, the need for drug or alcohol rehab depends on diagnosis, safety, functioning, environment, and the level of support required.
When is a screening score not enough?
A score is not enough when there is overdose, severe withdrawal, confusion, suicidal intent, pregnancy-related risk, major medical illness, or a mismatch between reported answers and observed impairment. Urgent symptoms require emergency evaluation regardless of the questionnaire result.
Screening also cannot determine a safe level of care by itself. Diagnosis, withdrawal and medical risk, psychiatric needs, functioning, recovery environment, preferences, and available services must be considered together.
Where can drug and alcohol screening occur?
Screening can occur in primary care, emergency departments, hospitals, behavioral-health programs, community settings, and other services with trained staff and a follow-up pathway. The setting should be able to protect privacy, explain the result, and connect the person with an appropriate next step.
What are the limits of drug and alcohol screening tests?
Screening can miss use, identify concern that later proves unfounded, or perform differently across populations and settings. Self-report can be affected by memory, stigma, fear, privacy, and interpretation of the questions; biological tests can be affected by the specimen, timing, cutoff, and test method.
Those limits do not make screening useless. They define its role: screening starts a risk conversation, while diagnostic assessment establishes the clinical picture and treatment planning addresses the person's needs.
Sources & References5ShowHide
- U.S. Preventive Services Task Force. Unhealthy Drug Use: Screening, 2020 — Defines screening for unhealthy drug use as asking questions and distinguishes screening from biological testing and diagnostic assessment.
- National Institute on Drug Abuse. Screening and Assessment Tools Chart — Lists current screening and assessment instruments by population and substance, including TAPS, DAST-10, BSTAD, S2BI, CRAFFT, and ASSIST.
- Substance Abuse and Mental Health Services Administration. Screening, Brief Intervention, and Referral to Treatment — Describes SBIRT as a public-health approach that combines screening, brief intervention, and referral.
- World Health Organization. AUDIT: The Alcohol Use Disorders Identification Test, 2001 — Official AUDIT manual describing the 10-item alcohol screening instrument and its use.
- National Institute on Alcohol Abuse and Alcoholism. Alcohol Use Disorder: From Risk to Diagnosis to Recovery — Explains that alcohol use disorder diagnosis requires clinical evaluation against DSM-5-TR symptoms rather than a screening score alone.